{"id":205130,"name":"GILEAD SCIENCES, INC.","slug":"gilead-sciences-inc","state":"CA","country":"United States of America","description":"Specialty biopharmaceutical company.","totalSpending":2020000,"filings":26,"yearlySpending":[{"year":2020,"income":290000},{"year":2021,"income":300000},{"year":2022,"income":320000},{"year":2023,"income":320000},{"year":2024,"income":430000},{"year":2025,"income":360000}],"issues":["HCR","BUD"],"firms":["FORBES-TATE"],"lobbyists":["ZACHARY WILLIAMS","DERRICK WHITE","BARRETT THORNHILL","CYNTHIA BROWN","ELIZABETH GREER","JEFFREY FORBES","MICHAEL WILLIAMS","KRISTINA DUNKLIN","ARTHUR SIDNEY","ANDRES RAMIREZ"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","White House Office"],"sampleDescriptions":["Issues related to healthcare.","Issues related to healthcare, including improving patient access to advanced immunology therapies and H.R. 748 - CARES Act (Public Law 116-136).","Issues related to healthcare, including improving patient access to advanced immunology therapies and H.R. 748 - CARES Act (Public Law 116-136).","Issues related to healthcare, including improving patient access to advanced immunology therapies and H.R. 748 - CARES Act (Public Law 116-136).","Issues related to H.R. 925 - The Heroes Act."],"years":[2020,2021,2022,2023,2024,2025]}